NF1 and central nervous system cancer: Molecularly, these gliomas are driven by inactivation of the NF1 tumor suppressor gene which encodes the neurofibromin protein that functions as a negative regulator of the RAS family of oncoproteins and downstream mitogen-activated protein (MAP) kinase signaling pathway [7, 16].